Modified Oligonucleotides for Treatment of Polycystic Kidney Disease
- 专利权人:
- Regulus Therapeutics; Inc.
- 发明人:
- Charles R. Allerson
- 申请号：
- US16463041
- 公开号：
- US20200165606A1
- 申请日:
- 2017.12.04
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- Provided herein are methods for the treatment of polycystic kidney disease, including autosomal dominant polycystic kidney disease, using modified oligonucleotides targeted to miR-17.
- 来源网站：
- 中国工程科技知识中心
